Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
93
-
Total shares
-
33.2M
-
Shares change
-
+4.55M
-
Total reported value, excl. options
-
$146M
-
Value change
-
+$18.9M
-
Put/Call ratio
-
5.71
-
Number of buys
-
44
-
Number of sells
-
-33
-
Price
-
$4.40
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q3 2018
97 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q3 2018.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.2M shares
.
Largest 10 shareholders include BlackRock Inc. (7.47M shares), STATE STREET CORP (6.96M shares), Vanguard Group Inc (5.42M shares), Invesco Ltd. (1.37M shares), NORTHERN TRUST CORP (1.29M shares), GEODE CAPITAL MANAGEMENT, LLC (991K shares), D. E. Shaw & Co., Inc. (887K shares), DEUTSCHE BANK AG\ (746K shares), Intellectus Partners, LLC (557K shares), and Wildcat Capital Management, LLC (416K shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.